000 01622 a2200445 4500
005 20250513051319.0
264 0 _c19940505
008 199405s 0 0 eng d
022 _a0022-1007
024 7 _a10.1084/jem.179.4.1215
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLevitsky, H I
245 0 0 _aIn vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
_h[electronic resource]
260 _bThe Journal of experimental medicine
_cApr 1994
300 _a1215-24 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBase Sequence
650 0 4 _aCD4-Positive T-Lymphocytes
_ximmunology
650 0 4 _aDNA
650 0 4 _aDown-Regulation
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_xadministration & dosage
650 0 4 _aHistocompatibility Antigens Class I
_xbiosynthesis
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMolecular Sequence Data
650 0 4 _aNeoplasm Transplantation
650 0 4 _aNeoplasms, Experimental
_ximmunology
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
650 0 4 _aTransduction, Genetic
650 0 4 _aTumor Cells, Cultured
650 0 4 _aVaccination
700 1 _aLazenby, A
700 1 _aHayashi, R J
700 1 _aPardoll, D M
773 0 _tThe Journal of experimental medicine
_gvol. 179
_gno. 4
_gp. 1215-24
856 4 0 _uhttps://doi.org/10.1084/jem.179.4.1215
_zAvailable from publisher's website
999 _c7907654
_d7907654